0.1000
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
26
26
--
26
701
Operating Expense
1,353
1,353
1,044
1,058
1,170
Operating Income
-1,327
-1,327
-1,044
-1,032
-469
Net Non Operating Interest Income Expense
2,452
2,452
2,261
646
--
Other Income Expense
--
--
--
646
7
Pretax Income
1,125
1,125
1,217
-386
-462
Tax Provision
347
347
-156
-200
7
Net Income Common Stockholders
-497
-497
98
-1,461
-2,492
Diluted NI Available to Com Stockholders
-497
-497
98
-1,461
-2,492
Basic EPS
-0.01
-0.01
0.00
-0.02
-0.03
Diluted EPS
-0.01
-0.01
0.00
-0.02
-0.03
Basic Average Shares
74,215
74,215
74,215
74,215
74,215
Diluted Average Shares
74,215
74,215
74,215
74,215
74,215
Total Operating Income as Reported
-1,327
-1,327
-1,044
-1,032
-469
Total Expenses
1,353
1,353
1,044
1,058
1,170
Net Income from Continuing & Discontinued Operation
778
778
1,373
-186
-469
Normalized Income
778
778
1,373
-186
-469
Interest Income
2,452
2,452
2,261
646
--
Net Interest Income
2,452
2,452
2,261
646
--
EBIT
-1,327
-1,327
-1,044
-1,032
-469
EBITDA
-1,327
-1,327
-1,044
-1,032
-469
Net Income from Continuing Operation Net Minority Interest
778
778
1,373
-186
-469
Normalized EBITDA
-1,327
-1,327
-1,044
-1,032
-469
Tax Rate for Calcs
0.0003
0.0003
0.0002
0.0002
0.0003
12/31/2021 - 2/15/1984
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
QNCX Quince Therapeutics, Inc.
0.9905
-0.95%
LYEL Lyell Immunopharma, Inc.
0.4336
-1.23%
CSCI COSCIENS Biopharma Inc.
2.8287
-2.12%
TECH Bio-Techne Corporation
48.10
-3.75%
XOMA XOMA Royalty Corporation
21.18
+3.17%
OGEN Oragenics, Inc.
0.1750
-2.02%
ENZC Enzolytics, Inc.
0.0007
+16.67%
VRAX Virax Biolabs Group Limited
0.9935
-3.54%
KZIA Kazia Therapeutics Limited
3.3000
-6.59%
SGMT Sagimet Biosciences Inc.
2.2100
+9.41%